Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Postoperative Complications | 7 | 2026 | 2962 | 0.350 |
Why?
|
| Hazardous Substances | 1 | 2009 | 16 | 0.290 |
Why?
|
| Neostigmine | 2 | 2021 | 21 | 0.290 |
Why?
|
| Cholinesterase Inhibitors | 2 | 2021 | 47 | 0.290 |
Why?
|
| Disease Susceptibility | 1 | 2009 | 343 | 0.250 |
Why?
|
| Environment | 1 | 2009 | 307 | 0.250 |
Why?
|
| Cognitive Dysfunction | 2 | 2023 | 470 | 0.250 |
Why?
|
| Alzheimer Disease | 2 | 2023 | 631 | 0.240 |
Why?
|
| Autistic Disorder | 1 | 2009 | 217 | 0.240 |
Why?
|
| Tennessee | 5 | 2026 | 57 | 0.190 |
Why?
|
| Dementia, Vascular | 1 | 2022 | 22 | 0.180 |
Why?
|
| Quality Improvement | 4 | 2021 | 1294 | 0.180 |
Why?
|
| Diagnosis-Related Groups | 1 | 2021 | 35 | 0.170 |
Why?
|
| Otorhinolaryngologic Diseases | 1 | 2021 | 17 | 0.170 |
Why?
|
| Surgical Procedures, Operative | 2 | 2015 | 272 | 0.160 |
Why?
|
| Acute Kidney Injury | 2 | 2026 | 873 | 0.160 |
Why?
|
| Robotics | 1 | 2021 | 90 | 0.150 |
Why?
|
| Postoperative Hemorrhage | 1 | 2021 | 106 | 0.150 |
Why?
|
| Otolaryngology | 1 | 2021 | 108 | 0.150 |
Why?
|
| Catheter-Related Infections | 1 | 2019 | 96 | 0.140 |
Why?
|
| Anastomotic Leak | 1 | 2018 | 45 | 0.140 |
Why?
|
| Inpatients | 1 | 2023 | 550 | 0.140 |
Why?
|
| Colorectal Surgery | 1 | 2018 | 30 | 0.140 |
Why?
|
| Ketorolac | 1 | 2018 | 32 | 0.140 |
Why?
|
| Robotic Surgical Procedures | 1 | 2021 | 183 | 0.140 |
Why?
|
| Hospital Mortality | 2 | 2021 | 1044 | 0.130 |
Why?
|
| Urinary Tract Infections | 1 | 2019 | 210 | 0.130 |
Why?
|
| Laparoscopy | 1 | 2021 | 481 | 0.120 |
Why?
|
| Neuromuscular Nondepolarizing Agents | 1 | 2016 | 33 | 0.120 |
Why?
|
| Venous Thromboembolism | 1 | 2021 | 327 | 0.120 |
Why?
|
| Intraoperative Care | 1 | 2016 | 63 | 0.120 |
Why?
|
| Transitional Care | 1 | 2016 | 45 | 0.120 |
Why?
|
| Perioperative Care | 1 | 2018 | 232 | 0.120 |
Why?
|
| Patient Handoff | 1 | 2016 | 44 | 0.120 |
Why?
|
| Neuromuscular Blockade | 1 | 2016 | 53 | 0.120 |
Why?
|
| Machine Learning | 1 | 2022 | 590 | 0.120 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 344 | 0.110 |
Why?
|
| Retrospective Studies | 10 | 2023 | 17269 | 0.110 |
Why?
|
| Patient Care Team | 1 | 2021 | 696 | 0.110 |
Why?
|
| Pneumonia, Ventilator-Associated | 1 | 2015 | 58 | 0.110 |
Why?
|
| Infection Control | 1 | 2015 | 174 | 0.100 |
Why?
|
| Palliative Care | 1 | 2022 | 1017 | 0.100 |
Why?
|
| Anesthesia | 1 | 2016 | 258 | 0.090 |
Why?
|
| Cross Infection | 1 | 2015 | 264 | 0.090 |
Why?
|
| tau Proteins | 2 | 2023 | 115 | 0.090 |
Why?
|
| Guideline Adherence | 1 | 2015 | 590 | 0.080 |
Why?
|
| Patient Satisfaction | 1 | 2015 | 710 | 0.080 |
Why?
|
| Humans | 20 | 2026 | 145491 | 0.080 |
Why?
|
| Amyloid beta-Peptides | 2 | 2023 | 248 | 0.080 |
Why?
|
| Respiration, Artificial | 1 | 2015 | 712 | 0.080 |
Why?
|
| Middle Aged | 11 | 2026 | 36176 | 0.080 |
Why?
|
| Incidence | 3 | 2026 | 2915 | 0.080 |
Why?
|
| Quality Assurance, Health Care | 1 | 2012 | 343 | 0.080 |
Why?
|
| Biomarkers | 3 | 2023 | 4283 | 0.070 |
Why?
|
| Glutathione Disulfide | 1 | 2009 | 32 | 0.070 |
Why?
|
| Intensive Care Units | 1 | 2015 | 925 | 0.070 |
Why?
|
| Sulfates | 1 | 2009 | 51 | 0.070 |
Why?
|
| Mercury | 1 | 2009 | 41 | 0.070 |
Why?
|
| Length of Stay | 3 | 2021 | 1348 | 0.070 |
Why?
|
| Risk Assessment | 3 | 2026 | 3759 | 0.070 |
Why?
|
| Cysteine | 1 | 2009 | 208 | 0.070 |
Why?
|
| Neoplasms | 1 | 2023 | 2897 | 0.070 |
Why?
|
| Cohort Studies | 3 | 2022 | 5992 | 0.060 |
Why?
|
| Risk Factors | 4 | 2026 | 10874 | 0.060 |
Why?
|
| Surgical Wound Infection | 2 | 2018 | 330 | 0.060 |
Why?
|
| Female | 11 | 2026 | 78763 | 0.050 |
Why?
|
| Diastole | 1 | 2005 | 146 | 0.050 |
Why?
|
| Systole | 1 | 2005 | 181 | 0.050 |
Why?
|
| ROC Curve | 1 | 2026 | 619 | 0.050 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2005 | 68 | 0.050 |
Why?
|
| Adult | 7 | 2022 | 40707 | 0.050 |
Why?
|
| Male | 10 | 2026 | 72817 | 0.050 |
Why?
|
| Aged | 5 | 2026 | 26125 | 0.050 |
Why?
|
| Databases, Factual | 2 | 2021 | 1500 | 0.050 |
Why?
|
| Patient Readmission | 2 | 2018 | 769 | 0.050 |
Why?
|
| United Kingdom | 1 | 2023 | 339 | 0.050 |
Why?
|
| Interleukin-8 | 1 | 2023 | 269 | 0.050 |
Why?
|
| Neuropathology | 1 | 2022 | 3 | 0.050 |
Why?
|
| Placenta Growth Factor | 1 | 2022 | 26 | 0.050 |
Why?
|
| Autopsy | 1 | 2022 | 95 | 0.040 |
Why?
|
| Interleukin-10 | 1 | 2023 | 313 | 0.040 |
Why?
|
| Goals | 1 | 2023 | 185 | 0.040 |
Why?
|
| Ventricular Function, Left | 1 | 2005 | 539 | 0.040 |
Why?
|
| Operative Time | 1 | 2021 | 181 | 0.040 |
Why?
|
| Colectomy | 1 | 2021 | 106 | 0.040 |
Why?
|
| Urinary Catheterization | 1 | 2019 | 33 | 0.040 |
Why?
|
| Urinalysis | 1 | 2019 | 83 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2023 | 772 | 0.040 |
Why?
|
| Reference Standards | 1 | 2019 | 178 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2022 | 550 | 0.040 |
Why?
|
| Adolescent | 3 | 2021 | 22485 | 0.040 |
Why?
|
| Mortality | 1 | 2021 | 379 | 0.030 |
Why?
|
| Elective Surgical Procedures | 1 | 2018 | 202 | 0.030 |
Why?
|
| Comorbidity | 1 | 2021 | 1659 | 0.030 |
Why?
|
| Communication | 1 | 2023 | 975 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2019 | 551 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2018 | 1001 | 0.030 |
Why?
|
| Causality | 1 | 2016 | 127 | 0.030 |
Why?
|
| Reoperation | 1 | 2018 | 631 | 0.030 |
Why?
|
| Interrupted Time Series Analysis | 1 | 2015 | 75 | 0.030 |
Why?
|
| Child | 2 | 2019 | 22680 | 0.030 |
Why?
|
| Risk | 1 | 2016 | 917 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2009 | 11837 | 0.020 |
Why?
|
| Registries | 1 | 2021 | 2410 | 0.020 |
Why?
|
| Vascular Surgical Procedures | 1 | 2015 | 348 | 0.020 |
Why?
|
| Hospitalization | 1 | 2022 | 2458 | 0.020 |
Why?
|
| Hospital Costs | 1 | 2012 | 125 | 0.020 |
Why?
|
| Pneumonia | 1 | 2016 | 632 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2021 | 8039 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2012 | 945 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 2379 | 0.020 |
Why?
|
| United States | 2 | 2015 | 16115 | 0.010 |
Why?
|
| Colforsin | 1 | 2005 | 47 | 0.010 |
Why?
|
| Endocardium | 1 | 2005 | 32 | 0.010 |
Why?
|
| Pericardium | 1 | 2005 | 59 | 0.010 |
Why?
|
| Myosin Heavy Chains | 1 | 2005 | 183 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2005 | 1047 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 8326 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2015 | 11831 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 14192 | 0.010 |
Why?
|